Literature DB >> 9472675

IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells.

T Kucharzik1, N Lügering, H G Pauels, W Domschke, R Stoll.   

Abstract

Several studies have demonstrated that intestinal epithelial cells play a major role in the initiation and perpetuation of intestinal inflammation by secreting proinflammatory cytokines and chemokines. MCP-1 is suggested to be a chemokine that plays a major part during intestinal inflammation in inflammatory bowel disease (IBD). Immunoregulatory cytokines such as IL-4, IL-10 and IL-13 have been described to exert anti-inflammatory properties on various cell types. The aim of our study was to determine the effect of Th2 cytokines on the production of MCP-1 by activated intestinal epithelial cells. We examined Caco-2 cells as well as intestinal epithelial cells which were isolated from surgical specimens. Production of the chemokine MCP-1 was determined under stimulated and non-stimulated conditions. IL-4, IL-10 and IL-13 were added to stimulated epithelial cells under various culture conditions. Supernatants were analysed for cytokine concentrations using ELISAs. Under stimulation with physiological agents like IL-1beta or tumour necrosis factor-alpha (TNF-alpha), we observed markedly increased concentrations of MCP-1 in supernatants of Caco-2 cells and intestinal epithelial cells. IL-4, IL-10 and IL-13 all had the capacity to down-regulate the production of MCP-1 in Caco-2 cells as well as in freshly isolated epithelial cells. Caco-2 cells which were primed with Th2 cytokines 24 h before stimulation were subsequently decreased in their ability to be stimulated by IL-1beta or TNF-alpha for MCP-1 production. As MCP-1 has been shown to play a major role during intestinal inflammation, the in vitro suppression of MCP-1 in enterocytes suggests the in vivo use of regulatory cytokines in patients with active IBD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472675      PMCID: PMC1904856          DOI: 10.1046/j.1365-2249.1998.00481.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Inhibition of colon and breast carcinoma cell growth by interleukin-4.

Authors:  M Toi; R Bicknell; A L Harris
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

2.  Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease.

Authors:  T Kucharzik; N Lügering; M Adolf; W Domschke; R Stoll
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

3.  Growth factor production by human colon carcinoma cell lines.

Authors:  M A Anzano; D Rieman; W Prichett; D F Bowen-Pope; R Greig
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

4.  Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.

Authors:  Y R Mahida; K Wu; D P Jewell
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

Review 5.  Transforming growth factor-beta in intestinal epithelial differentiation and neoplasia (review).

Authors:  S A Lamprecht; B Schwartz; A Glicksman
Journal:  Anticancer Res       Date:  1989 Nov-Dec       Impact factor: 2.480

6.  Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.

Authors:  F Cominelli; C C Nast; B D Clark; R Schindler; R Lierena; V E Eysselein; R C Thompson; C A Dinarello
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 7.  Human monocyte chemoattractant protein-1 (MCP-1).

Authors:  E J Leonard; T Yoshimura
Journal:  Immunol Today       Date:  1990-03

Review 8.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 9.  Properties of the novel proinflammatory supergene "intercrine" cytokine family.

Authors:  J J Oppenheim; C O Zachariae; N Mukaida; K Matsushima
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

10.  Interleukin-6 and its receptor are expressed in human intestinal epithelial cells.

Authors:  K Shirota; L LeDuy; S Y Yuan; S Jothy
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990
View more
  21 in total

1.  Colonic epithelial cells induce endothelial cell expression of ICAM-1 and VCAM-1 by a NF-kappaB-dependent mechanism.

Authors:  C Maaser; S Schoeppner; T Kucharzik; M Kraft; E Schoenherr; W Domschke; N Luegering
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 2.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice.

Authors:  B Sheil; J MacSharry; L O'Callaghan; A O'Riordan; A Waters; J Morgan; J K Collins; L O'Mahony; F Shanahan
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 4.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

5.  Interleukin-15 strongly inhibits interleukin-8 and monocyte chemoattractant protein-1 production in human colonic epithelial cells.

Authors:  N Lügering; T Kucharzik; C Maaser; M Kraft; W Domschke
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

6.  Control of chemokine production at the blood-retina barrier.

Authors:  I J Crane; C A Wallace; S McKillop-Smith; J V Forrester
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

7.  Characterization of conditions for the primary culture of human small intestinal epithelial cells.

Authors:  M C Aldhous; A N Shmakov; J Bode; S Ghosh
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

8.  Maltotriose Conjugated Metal-Organic Frameworks for Selective Targeting and Photodynamic Therapy of Triple Negative Breast Cancer Cells and Tumor Associated Macrophages.

Authors:  Yoshie Sakamaki; John Ozdemir; Alda Diaz Perez; Zachary Heidrick; Olivia Watson; Miu Tsuji; Chirstopher Salmon; Joseph Batta-Mpouma; Anthony Azzun; Valerie Lomonte; Yuchun Du; Julie Stenken; Jin Woo-Kim; M Hassan Beyzavi
Journal:  Adv Ther (Weinh)       Date:  2020-06-08

9.  Human intestinal epithelial cells down-regulate IL-8 expression in human intestinal microvascular endothelial cells; role of transforming growth factor-beta 1 (TGF-beta1).

Authors:  N Lügering; T Kucharzik; H Gockel; C Sorg; R Stoll; W Domschke
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

10.  Interleukin (IL)-4 induces leukocyte infiltration in vivo by an indirect mechanism.

Authors:  Claude Ratthé; Jamila Ennaciri; David M Garcês Gonçalves; Sonia Chiasson; Denis Girard
Journal:  Mediators Inflamm       Date:  2009-09-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.